Outcomes in Emergency Laparotomies During COVID-19 Pandemic
- Conditions
- Emergency General SurgeryCOVID-19
- Interventions
- Procedure: Emergency Laparotomy
- Registration Number
- NCT04419571
- Brief Summary
NLR has previously been observed to correlate with complications in upper GI (1) and colorectal (2) surgery. The investigators sought to assess if a similar correlation can be identified in emergency general surgical patients and if the presence of suspected or confirmed COVID-19 may impact on this.
Given the heterogeneity of emergency general surgery the investigators therefore plan to perform a retrospective review of patients having emergency laparotomies only at a single NHS site during COVID-19 pandemic. Assessment of outcomes and Neutrophil:lymphocyte ratio as a predictor of outcomes will be completed. Outcomes will be completed in line with the recent COVIDSurg study criteria (3). The primary outcome is 30-day mortality. Secondary outcomes are 7-day mortality, re-operation, length of stay, post-operative respiratory failure, post-operative ARDS (Acute Respiratory Distress Syndrome), post-operative sepsis and ITU (Intensive Therapy Unit)/HDU (High Dependency Unit) admission.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 94
- Patients undergoing emergency laparotomy (change made due to heterogeneity of emergency general surgery)
- Inherited or acquired immunodeficiency (which may directly skew NLR)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Negative or non-suspected COVID-19 Emergency Laparotomy All adult patients (\>17 years) undergoing emergency (laparotomy) surgery at a single centre (Queens Hospital, Romford, UK) without clinically or radiologically suspected COVID-19, or without viral PCR (Polymerase Chain Reaction) confirmation. Suspected or Confirmed COVID-19 Emergency Laparotomy All adult patients (\>17 years) undergoing emergency (laparotomy) surgery at a single centre (Queens Hospital, Romford, UK) with clinically or radiologically suspected COVID-19, or with viral PCR confirmation; diagnosis made 7-days before and 30-days after date of surgery in accordance with the COVIDsurg study criteria (3).
- Primary Outcome Measures
Name Time Method 30-day mortality 30 days Mortality
- Secondary Outcome Measures
Name Time Method Number of participants returning to theatre 30 days Re-operation
Length of stay 30 days Inpatient stay during index admission
Post-operative respiratory failure 30 days Presence of respiratory failure in the post-operative period as defined in the clinical notes or discharge summaries
Post-operative ARDS 30 days ARDS diagnosed radiologically
ITU/HDU admission 30 days ITU/HDU admission post-operatively
7-day mortality 7 days Mortality
Post-operative sepsis 30 days Presence of sepsis in the post-operative period as defined in the clinical notes or discharge summaries
Trial Locations
- Locations (1)
Queen's Hospital
🇬🇧Romford, United Kingdom